ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents (original) (raw)
Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell.74, 957–967 (1993). ArticleCASPubMed Google Scholar
Fujiwara, T. et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res.54, 2287–2291 (1994). CASPubMed Google Scholar
Lowe, S.W. et al. p53 status and the efficacy of cancer therapy in vivo. Science266, 807–810 (1994). ArticleCASPubMed Google Scholar
Fearon, E.R., Hamilton, S.R. & Vogelstein, B. Clonal analysis of human colorectal tumors. Science238, 193–197 (1990). Article Google Scholar
Brennan, J.A. et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med.332, 429–435 (1995). ArticleCASPubMed Google Scholar
Chang, F., Syrjanen, S. & Syrjanen, K. Implications of the p53 tumor-suppressor gene in clinical oncology. J. clin. Oncol.13, 1009–1022 (1995). ArticleCASPubMed Google Scholar
Bergh, J., Norberg, T., Sjögren, S., Lindgren, A. & Holmberg, L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature Med.1, 1029–1034 (1995). ArticleCASPubMed Google Scholar
Eliopoulos, A.G. et al. The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2. Oncogene11, 1217–1228 (1995). CASPubMed Google Scholar
Debbas, M. & White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev.7, 546–554 (1993). ArticleCASPubMed Google Scholar
Grand, R.J., Grant, M.L. & Gallimore, P.H. Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology203, 229–240 (1994). ArticleCASPubMed Google Scholar
Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell74, 957–967 (1993). ArticleCASPubMed Google Scholar
Lechner, M.S. et al. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J.11, 3045–3052 (1992). ArticleCASPubMedPubMed Central Google Scholar
Gannon, J.V. & Lane, D.P. p53 and DNA polymerase alpha compete for binding to SV40 T antigen. Nature329, 456–458 (1987). ArticleCASPubMed Google Scholar
Barker, D.D. & Berk, A.J. Adenovirus proteins from both El B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology156, 107–121 (1987). ArticleCASPubMed Google Scholar
Slichenmeyer, W.J., Nelson, W.G., Slebos, R.J. & Kastan, M.B. Loss of a p53-associated G1 checkpoint does not decrease cell survival Cancer Res.53 4164–4169 (1993 Google Scholar
Bischoff, J.R. et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science274, 373–376 (1996). ArticleCASPubMed Google Scholar
MacCallum, D. et al. The p53 response to ionizing radiation in adult and developing tissues. Oncogene13, 2575–2587 (1996). CASPubMed Google Scholar
Brown, B. et al. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int. J. Cancer55, 678–684 (1993). ArticleCASPubMed Google Scholar
Li, C., Nagasawa, H., Dahlberg, W. & Little, J. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene11, 1885–1892 (1995). CASPubMed Google Scholar
Wills, K.N. et al. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum. Gene Ther.5, 1079–88 (1994). ArticleCASPubMed Google Scholar
Clayman, G.L. et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res.55, 1–6 (1995). CASPubMed Google Scholar
Roth, J. et al. p53 as a target for cancer vaccines: Recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge. Proc. Natl. Acad. Sci. USA93, 4781–4786 (1996). ArticleCASPubMedPubMed Central Google Scholar
Kim, D.H. Replicating oncolytic viruses: An overview. Expert Opin. Invest. Invest Drugs5, 753–762 (1996). Article Google Scholar
Sanchez-Prieto, R. et al. Carcinoma cells become sensitive to DNA-damaging agents by the expression of the adenovirus E1 A gene. Oncogene13, 1083–1092 (1996). PubMed Google Scholar
Debbas, M. & White, E. Wild-type p53 mediates apoptosis by El A, which is inhibited by E1 B. Genes Dev.7, 546–554 (1993). ArticleCASPubMed Google Scholar
Engelhardt, J.F. et al. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature Genet.4, 27–34 (1993). ArticleCASPubMed Google Scholar
Wilson, J.M., Engelhardt, J.F., Grossman, M., Simon, R.H. & Yang, Y. Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: A phase I trail. Hum. Gene Ther.5, 501–519 (1994). ArticleCASPubMed Google Scholar
Fearon, E.R., Itaya, T., Hunt, B., Vogelstein, B. & Frost, P. Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene. Cancer Res.48, 2975–2980 (1988). CASPubMed Google Scholar
Dvorak, H.F., Nagy, J.A., Dvorak, J.T. & Dvorak, A.M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol.133, 95–109 (1988). CASPubMedPubMed Central Google Scholar
Ginsberg, H.S. & Prince, G.A. The molecular basis of adenovirus pathogenesis. Infect Agents Dis.3, 1–8 (1994). CASPubMed Google Scholar
Scheffner, M., Munger, K., Byrne, J.C. & Howley, P.M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA88, 5523–5527 (1991). ArticleCASPubMedPubMed Central Google Scholar
Wang, N., To, H., Lee, W. & Lee, E. Tumor suppressor activity of Rb and p53 genes in human breast carcinoma cells. Oncogene8, 279–288 (1993). CASPubMed Google Scholar
Van Meir, E.G. et al. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res.54, 649–652 (1994). CASPubMed Google Scholar
Hsu, I.C. et al. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer lines. Carcinogenesis14, 987–992 (1993). ArticleCASPubMed Google Scholar
Yaginuma, Y. & Westphal, H. Abnormal structure and function of the p53 gene in human ovarian carcinoma cell lines. Cancer Res.52, 4196–4199 (1992). CASPubMed Google Scholar
Ruggeri, B. et al. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene7, 1503–1511 (1992). CASPubMed Google Scholar
Hsu, I.C. et al. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis14, 987–992 (1993). ArticleCASPubMed Google Scholar
Waldman, T., Kinzler, K.W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res.55, 5187–5190 (1995). CASPubMed Google Scholar